TRAW Stock Analysis: Buy, Sell, or Hold?
TRAW - Traws Pharma, Inc. Common Stock
$1.64
-0.02 (-1.20%)
▼
5d:
-15.03%
30d:
-2.38%
90d:
+45.13%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When TRAW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TRAW shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TRAW shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TRAW is currently trading at $1.64, which is considered slightly low relative to its 30-day fair value range of $1.63 to $2.07.
Technical Outlook: Technically, TRAW is showing sideways momentum. Immediate support is located at $1.49, while resistance sits at $2.29.
Market Sentiment: TRAW has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+387.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TRAW is showing sideways momentum. Immediate support is located at $1.49, while resistance sits at $2.29.
Market Sentiment: TRAW has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+387.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.63 -
$2.07
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 387.8% below Wall St target ($8.00)
- CAUTION: 5-day price weakness (-15.0%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.63 -
$2.07
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.49
Resistance Level
$2.29
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.71
Wall Street Target
$8.00
(+387.8%)
Revenue Growth (YoY)
4694.7%
Share & Embed Analysis
Last updated: April 05, 2026 1:35 PM ET
Data refreshes hourly during market hours. Next update: 2:35 PM
Data refreshes hourly during market hours. Next update: 2:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRAW showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 50 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 58 HOLD |